Related Experiment Video
Updated: Feb 7, 2026

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
Published on: June 6, 2025
Pediatric Neurodevelopmental Functioning After In Utero Exposure to Triple-NRTI vs. Dual-NRTI + PI ART in a
Deborah Kacanek1, Paige L Williams1, Gloria Mayondi2
1Department of Biostatistics, Center for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, MA.
Insights
HIV-exposed uninfected children showed similar neurodevelopmental outcomes regardless of maternal antiretroviral treatment (ART) regimen. This suggests no short-term toxicity from nucleoside reverse transcriptase inhibitor (NRTI)-based ART in pregnant women.
Area of Science:
- Pediatrics
- Infectious Diseases
- Neuroscience
Background:
- Antiretroviral treatment (ART) regimens containing nucleoside reverse transcriptase inhibitors (NRTIs) are used in HIV-infected pregnant women.
- Potential neurodevelopmental effects of in utero ART exposure in HIV-exposed uninfected (HEU) children require investigation.
Purpose of the Study:
- To compare neurodevelopmental outcomes in HEU children exposed to different ART regimens in utero.
- To assess potential short-term neurotoxicity associated with NRTI-containing ART regimens.
Main Methods:
- The Mma Bana randomized trial compared a triple-NRTI regimen with a dual-NRTI + protease inhibitor (PI) regimen in HIV-infected pregnant women.
- Neurodevelopmental assessments were conducted at 24 months of age in HEU children using standardized tools.
- Statistical analyses evaluated differences in neurodevelopmental scores between the two ART exposure groups.
Main Results:
- A total of 197 HEU children (101 triple-NRTI, 96 dual-NRTI + PI) completed neurodevelopmental assessments.
- Mean neurodevelopmental scores were similar across both ART exposure groups.
- No significant differences were observed in any neurodevelopmental outcomes between the groups in unadjusted or adjusted models.
Conclusions:
- In utero exposure to dual-NRTI + PI-based or triple-NRTI-based ART regimens did not result in significant differences in neurodevelopmental outcomes at 24 months in HEU children.
- Findings suggest a lack of short-term neurodevelopmental toxicity associated with these ART regimens.
- Long-term toxicity monitoring and evaluation of newer ART regimens are recommended.
Background:
In utero exposure to nucleoside reverse transcriptase inhibitor (NRTI)-containing antiretroviral treatment (ART) regimens may be associated with poor neurodevelopmental functioning in children of HIV-infected mothers. We investigated neurodevelopmental outcomes of HIV-exposed uninfected (HEU) children of HIV-infected women enrolled in a randomized trial of abacavir/zidovudine/lamivudine (triple-NRTI regimen) vs. lopinavir/ritonavir/zidovudine/lamivudine [dual-NRTI + protease inhibitor (PI) regimen].
Setting:
The Mma Bana randomized trial was conducted in urban and rural sites in Botswana.
Methods:
The Mma Bana study randomized HIV-infected pregnant women with CD4 ≥200 cells per mm to a triple-NRTI vs. dual-NRTI + PI regimen from 26- to 34-week gestation through planned weaning at 6-month postpartum. Partway through the study, neurodevelopmental assessments were added at 24 months of age, including the Developmental Milestones Checklist, the Bayley Scales of Infant and Toddler Development third edition, Ten Questions Questionnaire, and Profile of Social Emotional Development. We evaluated differences in mean scores between the 2 arms using unadjusted and adjusted linear regression.
Results:
A total of 197 HEU infants (48% male) completed a neurodevelopmental assessment (101 in triple-NRTI arm and 96 in dual-NRTI + PI-exposed arm). Mean values for all neurodevelopmental outcomes were similar for children of mothers randomized to either ART regimen, with no significant differences in either unadjusted or adjusted models (estimated effect sizes ranging from -0.12 to 0.14).
Conclusions:
Neurodevelopmental outcomes in 24-month-old HEU children of HIV-infected mothers with baseline CD4 ≥200 were similar in those randomized to a dual-NRTI + PI-based vs. a triple-NRTI-based ART regimen, suggestive of lack of short-term toxicity. Monitoring of long-term toxicity and newer regimens is warranted.
Related Concept Videos
PI Controller: Design
The Buckingham Pi Theorem
Determination of Pi Terms
The theorem indicates that the...
Clinical Trials: Overview
Trial and Error and Algorithm
Clinical Trials
There are four phases in a clinical trial. A phase one...

